Recombinant Cynomolgus IFNB1 cell lysate
Cat.No. : | IFNB1-889CCL |
Product Overview : | Cynomolgus IFNB1 / IFN-beta / Interferon beta derived in Human Cells. The whole cell lysate is provided in 1X Sample Buffer.Browse all transfected cell lysate positive controls |
- Specification
- Gene Information
- Related Products
Source : | Human cells |
Species : | Cynomolgus |
Preparation method : | Transfected cells were cultured for 48hrs before collection. The cells were lysed in modified RIPA buffer with cocktail of protease inhibitors. Cell debris was removed by centrifugation and then centrifuged to clarify the lysate. The cell lysate was boiled for 5 minutes in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% b-mercaptoethanol, and lyophilized. |
Lysis buffer : | Modified RIPA Lysis Buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF |
Quality control Testing : | 12.5% SDS-PAGE Stained with Coomassie Blue |
Recommended Usage : | 1. Centrifuge the tube for a few seconds and ensure the pellet at the bottom of the tube.2. Re-dissolve the pellet using 200μL pure water and boiled for 2-5 min.3. Store it at -80°C. Recommend to aliquot the cell lysate into smaller quantities for optimal storage. Avoid repeated freeze-thaw cycles.Notes:The lysate is ready to load on SDS-PAGE for Western blot application. If dissociating conditions are required, add reducing agent prior to heating. |
Stability : | Samples are stable for up to twelve months from date of receipt at -80°C |
Storage Buffer : | 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF |
Storage Instruction : | Lysate samples are stable for 12 months from date of receipt when stored at -80°C. Avoid repeated freeze-thaw cycles. Prior to SDS-PAGE fractionation, boil the lysate for 5 minutes. |
Gene Name : | IFNB1 interferon, beta 1, fibroblast [ Macaca fascicularis ] |
Official Symbol : | IFNB1 |
Synonyms : | interferon, beta 1, fibroblast |
Gene ID : | 102115670 |
mRNA Refseq : | XM_005581636 |
Protein Refseq : | XP_005581693 |
Chromosome Location : | chromosome: 15 |
Pathway : | Chagas disease (American trypanosomiasis), organism-specific biosystem; Cytokine-cytokine receptor interaction, organism-specific biosystem; Hepatitis C, organism-specific biosystem |
Products Types
◆ Recombinant Protein | ||
IFNB1-2652R | Recombinant Rat IFNB1 Protein, His (Fc)-Avi-tagged | +Inquiry |
IFNB1-155H | Active Recombinant Human IFNB1 Protein (Met22-Asn187), C-His tagged, Animal-free, Carrier-free | +Inquiry |
IFNB1-2724R | Recombinant Rhesus monkey IFNB1 Protein, His&GST-tagged | +Inquiry |
IFNB1-2271P | Recombinant Pig IFNB1 Protein, His-tagged | +Inquiry |
IFNB1-082H | Active Recombinant Human IFNB1 Protein | +Inquiry |
◆ Lysates | ||
IFNB1-001HCL | Recombinant Human IFNB1 cell lysate | +Inquiry |
IFNB1-2931HCL | Recombinant Human IFNB1 cell lysate | +Inquiry |
IFNB1-1117MCL | Recombinant Mouse IFNB1 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionIFNB1 is generally not recommended for individuals with a history of hypersensitivity to interferons or other components of the drug. It should be used with caution in patients with certain pre-existing medical conditions.
IFNB1 is being investigated for its potential role in cancer treatment due to its immunomodulatory effects. Clinical trials are ongoing to evaluate its efficacy in various types of cancer.
Common side effects include flu-like symptoms, injection site reactions, and changes in blood cell counts. Serious side effects are rare but can include liver problems and allergic reactions.
IFNB1 is often administered through subcutaneous or intramuscular injections. The frequency and dosage depend on the specific condition being treated.
IFNB1 is also used in the treatment of certain viral infections, such as hepatitis B and C. It has antiviral properties that can inhibit viral replication.
Customer Reviews (3)
Write a reviewThe manufacturer not only ensures the provision of superior protein but also aids researchers with their solid technical support, offering the necessary resources to optimize experimental protocols.
the IFNB1 protein offers numerous advantages for researchers conducting trials due to its high quality and stability.
manufacturers or suppliers of proteins can play a crucial role in supporting researchers during trials.
Ask a Question for All IFNB1 Products
Required fields are marked with *
My Review for All IFNB1 Products
Required fields are marked with *
Inquiry Basket